{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:37:56Z","timestamp":1793745476962,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in Aid for Scientific Research","award":["17H04031"],"award-info":[{"award-number":["17H04031"]}]},{"name":"Grant-in Aid for Scientific Research","award":["17H04252"],"award-info":[{"award-number":["17H04252"]}]},{"name":"Grant-in Aid for Scientific Research","award":["17H02220"],"award-info":[{"award-number":["17H02220"]}]},{"name":"Grant-in Aid for Challenging Exploratory Research","award":["16K15201"],"award-info":[{"award-number":["16K15201"]}]},{"name":"Grant-in Aid for Challenging Exploratory Research","award":["17K19483"],"award-info":[{"award-number":["17K19483"]}]},{"name":"Grant-in Aid for Scientific Research on Innovative Areas","award":["24111518"],"award-info":[{"award-number":["24111518"]}]},{"name":"Grant-in Aid for Young Scientists","award":["16K21080"],"award-info":[{"award-number":["16K21080"]}]},{"name":"Private University Research Branding Project"},{"name":"the Astellas Foundation for Research on Metabolic Disorders"},{"name":"The Hori Science and Arts Foundation"},{"name":"Grant for Biomedical Research from Smoking Research Foundation"},{"DOI":"10.13039\/100008732","name":"the Uehara Memorial Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Strategic Research Program for Brain Sciences, and Research on Regulatory Science of Pharmaceuticals and Medical Devices"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1332-0","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:36:21Z","timestamp":1540215381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3"],"prefix":"10.1186","volume":"15","author":[{"given":"Shinnosuke","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimichi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyofumi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,22]]},"reference":[{"key":"1332_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.schres.2014.09.015","volume":"159","author":"Y Luo","year":"2014","unstructured":"Luo Y, He H, Zhang M, Huang X, Zhang J, Zhou Y, Liu X, Fan N. Elevated serum levels of TNF-alpha, IL-6 and IL-18 in chronic schizophrenic patients. Schizophr Res. 2014;159:556\u20137.","journal-title":"Schizophr Res"},{"key":"1332_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","volume":"41","author":"A Stojanovic","year":"2014","unstructured":"Stojanovic A, Martorell L, Montalvo I, Ortega L, Monseny R, Vilella E, Labad J. Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms. Psychoneuroendocrinology. 2014;41:23\u201332.","journal-title":"Psychoneuroendocrinology"},{"key":"1332_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.psychres.2016.02.052","volume":"239","author":"FM Schmidt","year":"2016","unstructured":"Schmidt FM, Schroder T, Kirkby KC, Sander C, Suslow T, Holdt LM, Teupser D, Hegerl U, Himmerich H. Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression. Psychiatry Res. 2016;239:85\u201391.","journal-title":"Psychiatry Res"},{"key":"1332_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/archpsyc.61.8.774","volume":"61","author":"AS Brown","year":"2004","unstructured":"Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004;61:774\u201380.","journal-title":"Arch Gen Psychiatry"},{"key":"1332_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.schres.2012.05.023","volume":"139","author":"GM Khandaker","year":"2012","unstructured":"Khandaker GM, Zimbron J, Dalman C, Lewis G, Jones PB. Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res. 2012;139:161\u20138.","journal-title":"Schizophr Res"},{"key":"1332_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1017\/S0033291712000736","volume":"43","author":"GM Khandaker","year":"2013","unstructured":"Khandaker GM, Zimbron J, Lewis G, Jones PB. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med. 2013;43:239\u201357.","journal-title":"Psychol Med"},{"key":"1332_CR7","doi-asserted-by":"publisher","first-page":"28218","DOI":"10.3390\/ijms161226092","volume":"16","author":"D Ibi","year":"2015","unstructured":"Ibi D, Yamada K. Therapeutic targets for neurodevelopmental disorders emerging from animal models with perinatal immune activation. Int J Mol Sci. 2015;16:28218\u201329.","journal-title":"Int J Mol Sci"},{"key":"1332_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fncel.2015.00261","volume":"9","author":"Y Koyama","year":"2015","unstructured":"Koyama Y. Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target. Front Cell Neurosci. 2015;9:261.","journal-title":"Front Cell Neurosci"},{"key":"1332_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","volume":"1","author":"CC Bailey","year":"2014","unstructured":"Bailey CC, Zhong G, Huang IC, Farzan M. IFITM-family proteins: the cell\u2019s first line of antiviral defense. Annu Rev Virol. 2014;1:261\u201383.","journal-title":"Annu Rev Virol"},{"key":"1332_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2217\/fmb.14.65","volume":"9","author":"NM Chesarino","year":"2014","unstructured":"Chesarino NM, McMichael TM, Yount JS. Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications. Future Microbiol. 2014;9:1151\u201363.","journal-title":"Future Microbiol"},{"key":"1332_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10921","volume":"484","author":"AR Everitt","year":"2012","unstructured":"Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB, Gen II, Investigators M, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P. IFITM3 restricts the morbidity and mortality associated with influenza. Nature. 2012;484:519\u201323.","journal-title":"Nature"},{"key":"1332_CR12","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","volume":"139","author":"AL Brass","year":"2009","unstructured":"Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell. 2009;139:1243\u201354.","journal-title":"Cell"},{"key":"1332_CR13","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1038\/tp.2013.94","volume":"3","author":"Y Hwang","year":"2013","unstructured":"Hwang Y, Kim J, Shin JY, Kim JI, Seo JS, Webster MJ, Lee D, Kim S. Gene expression profiling by mRNA sequencing reveals increased expression of immune\/inflammation-related genes in the hippocampus of individuals with schizophrenia. Transl Psychiatry. 2013;3:e321.","journal-title":"Transl Psychiatry"},{"key":"1332_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.biopsych.2013.06.010","volume":"75","author":"S Horvath","year":"2014","unstructured":"Horvath S, Mirnics K. Immune system disturbances in schizophrenia. Biol Psychiatry. 2014;75:316\u201323.","journal-title":"Biol Psychiatry"},{"key":"1332_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-244X-7-46","volume":"7","author":"P Saetre","year":"2007","unstructured":"Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E. Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry. 2007;7:46.","journal-title":"BMC Psychiatry"},{"key":"1332_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neures.2009.03.015","volume":"64","author":"D Ibi","year":"2009","unstructured":"Ibi D, Nagai T, Kitahara Y, Mizoguchi H, Koike H, Shiraki A, Takuma K, Kamei H, Noda Y, Nitta A, Nabeshima T, Yoneda Y, Yamada K. Neonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood. Neurosci Res. 2009;64:297\u2013305.","journal-title":"Neurosci Res"},{"key":"1332_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/glia.22461","volume":"61","author":"D Ibi","year":"2013","unstructured":"Ibi D, Nagai T, Nakajima A, Mizoguchi H, Kawase T, Tsuboi D, Kano S, Sato Y, Hayakawa M, Lange UC, Adams DJ, Surani MA, Satoh T, Sawa A, Kaibuchi K, Nabeshima T, Yamada K. Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice. Glia. 2013;61:679\u201393.","journal-title":"Glia"},{"key":"1332_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.bbi.2014.02.014","volume":"38","author":"S Yamada","year":"2014","unstructured":"Yamada S, Nagai T, Nakai T, Ibi D, Nakajima A, Yamada K. Matrix metalloproteinase-3 is a possible mediator of neurodevelopmental impairment due to polyI:C-induced innate immune activation of astrocytes. Brain Behav Immun. 2014;38:272\u201382.","journal-title":"Brain Behav Immun"},{"key":"1332_CR19","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1128\/MCB.00272-08","volume":"28","author":"UC Lange","year":"2008","unstructured":"Lange UC, Adams DJ, Lee C, Barton S, Schneider R, Bradley A, Surani MA. Normal germ line establishment in mice carrying a deletion of the Ifitm\/Fragilis gene family cluster. Mol Cell Biol. 2008;28:4688\u201396.","journal-title":"Mol Cell Biol"},{"key":"1332_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2009.08.027","volume":"206","author":"D Ibi","year":"2010","unstructured":"Ibi D, Nagai T, Koike H, Kitahara Y, Mizoguchi H, Niwa M, Jaaro-Peled H, Nitta A, Yoneda Y, Nabeshima T, Sawa A, Yamada K. Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood. Behav Brain Res. 2010;206:32\u20137.","journal-title":"Behav Brain Res"},{"key":"1332_CR21","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/glia.23299","volume":"66","author":"A Sobue","year":"2018","unstructured":"Sobue A, Ito N, Nagai T, Shan W, Hada K, Nakajima A, Murakami Y, Mouri A, Yamamoto Y, Nabeshima T, Saito K, Yamada K. Astroglial major histocompatibility complex class I following immune activation leads to behavioral and neuropathological changes. Glia. 2018;66:1034\u201352.","journal-title":"Glia"},{"key":"1332_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4049\/jimmunol.182.1.234","volume":"182","author":"SD Clutter","year":"2009","unstructured":"Clutter SD, Wilson DC, Marinov AD, Hirsch R. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. J Immunol. 2009;182:234\u20139.","journal-title":"J Immunol"},{"key":"1332_CR23","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1002\/art.27485","volume":"62","author":"DC Wilson","year":"2010","unstructured":"Wilson DC, Marinov AD, Blair HC, Bushnell DS, Thompson SD, Chaly Y, Hirsch R. Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2010;62:2510\u20136.","journal-title":"Arthritis Rheum"},{"key":"1332_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.febslet.2012.01.010","volume":"586","author":"K Murakami","year":"2012","unstructured":"Murakami K, Tanaka M, Usui T, Kawabata D, Shiomi A, Iguchi-Hashimoto M, Shimizu M, Yukawa N, Yoshifuji H, Nojima T, Ohmura K, Fujii T, Umehara H, Mimori T. Follistatin-related protein\/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4. FEBS Lett. 2012;586:319\u201324.","journal-title":"FEBS Lett"},{"key":"1332_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10735-016-9706-z","volume":"48","author":"KY Cheng","year":"2017","unstructured":"Cheng KY, Liu Y, Han YG, Li JK, Jia JL, Chen B, Yao ZX, Nie L, Cheng L. Follistatin-like protein 1 suppressed pro-inflammatory cytokines expression during neuroinflammation induced by lipopolysaccharide. J Mol Histol. 2017;48:63\u201372.","journal-title":"J Mol Histol"},{"key":"1332_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2015.11.003","volume":"103","author":"MK Jha","year":"2016","unstructured":"Jha MK, Lee WH, Suk K. Functional polarization of neuroglia: implications in neuroinflammation and neurological disorders. Biochem Pharmacol. 2016;103:1\u201316.","journal-title":"Biochem Pharmacol"},{"key":"1332_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S2215-0366(17)30101-3","volume":"4","author":"V Mondelli","year":"2017","unstructured":"Mondelli V, Vernon AC, Turkheimer F, Dazzan P, Pariante CM. Brain microglia in psychiatric disorders. Lancet Psychiatry. 2017;4:563.","journal-title":"Lancet Psychiatry"},{"key":"1332_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0079-6123(09)17509-X","volume":"175","author":"JM van Noort","year":"2009","unstructured":"van Noort JM, Bsibsi M. Toll-like receptors in the CNS: implications for neurodegeneration and repair. Prog Brain Res. 2009;175:139\u201348.","journal-title":"Prog Brain Res"},{"key":"1332_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.schres.2013.10.040","volume":"151","author":"BM Ribeiro","year":"2013","unstructured":"Ribeiro BM, do Carmo MR, Freire RS, Rocha NF, Borella VC, de Menezes AT, Monte AS, Gomes PX, de Sousa FC, Vale ML, de Lucena DF, Gama CS, Macedo D. Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine. Schizophr Res. 2013;151:12\u20139.","journal-title":"Schizophr Res"},{"key":"1332_CR30","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.4049\/jimmunol.177.7.4758","volume":"177","author":"T Miyamae","year":"2006","unstructured":"Miyamae T, Marinov AD, Sowders D, Wilson DC, Devlin J, Boudreau R, Robbins P, Hirsch R. Follistatin-like protein-1 is a novel proinflammatory molecule. J Immunol. 2006;177:4758\u201362.","journal-title":"J Immunol"},{"key":"1332_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13075-015-0605-6","volume":"17","author":"S Ni","year":"2015","unstructured":"Ni S, Miao K, Zhou X, Xu N, Li C, Zhu R, Sun R, Wang Y. The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-kappaB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation. Arthritis Res Ther. 2015;17:91.","journal-title":"Arthritis Res Ther"},{"key":"1332_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.yexcr.2017.02.025","volume":"352","author":"ZM Zhang","year":"2017","unstructured":"Zhang ZM, Zhang AR, Xu M, Lou J, Qiu WQ. TLR-4\/miRNA-32-5p\/FSTL1 signaling regulates mycobacterial survival and inflammatory responses in mycobacterium tuberculosis-infected macrophages. Exp Cell Res. 2017;352:313\u201321.","journal-title":"Exp Cell Res"},{"key":"1332_CR33","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1186\/ar3241","volume":"13","author":"D Li","year":"2011","unstructured":"Li D, Wang Y, Xu N, Wei Q, Wu M, Li X, Zheng P, Sun S, Jin Y, Zhang G, Liao R, Zhang P. Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis. Arthritis Res Ther. 2011;13:R17.","journal-title":"Arthritis Res Ther"},{"key":"1332_CR34","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1681\/ASN.2014020210","volume":"26","author":"S Hayakawa","year":"2015","unstructured":"Hayakawa S, Ohashi K, Shibata R, Kataoka Y, Miyabe M, Enomoto T, Joki Y, Shimizu Y, Kambara T, Uemura Y, Yuasa D, Ogawa H, Matsuo K, Hiramatsu-Ito M, van den Hoff MJ, Walsh K, Murohara T, Ouchi N. Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model. J Am Soc Nephrol. 2015;26:636\u201346.","journal-title":"J Am Soc Nephrol"},{"key":"1332_CR35","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1074\/jbc.M109.069468","volume":"285","author":"N Ouchi","year":"2010","unstructured":"Ouchi N, Asaumi Y, Ohashi K, Higuchi A, Sono-Romanelli S, Oshima Y, Walsh K. DIP2A functions as a FSTL1 receptor. J Biol Chem. 2010;285:7127\u201334.","journal-title":"J Biol Chem"},{"key":"1332_CR36","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1111\/j.1742-4658.2010.07816.x","volume":"277","author":"M Tanaka","year":"2010","unstructured":"Tanaka M, Murakami K, Ozaki S, Imura Y, Tong XP, Watanabe T, Sawaki T, Kawanami T, Kawabata D, Fujii T, Usui T, Masaki Y, Fukushima T, Jin ZX, Umehara H, Mimori T. DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein\/follistatin-like 1--analysis of their binding with TGF-beta superfamily proteins. FEBS J. 2010;277:4278\u201389.","journal-title":"FEBS J"},{"key":"1332_CR37","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1073\/pnas.1007293108","volume":"108","author":"Y Geng","year":"2011","unstructured":"Geng Y, Dong Y, Yu M, Zhang L, Yan X, Sun J, Qiao L, Geng H, Nakajima M, Furuichi T, Ikegawa S, Gao X, Chen YG, Jiang D, Ning W. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proc Natl Acad Sci U S A. 2011;108:7058\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1332_CR38","doi-asserted-by":"publisher","first-page":"e22616","DOI":"10.1371\/journal.pone.0022616","volume":"6","author":"M Sylva","year":"2011","unstructured":"Sylva M, Li VS, Buffing AA, van Es JH, van den Born M, van der Velden S, Gunst Q, Koolstra JH, Moorman AF, Clevers H, van den Hoff MJ. The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis. PLoS One. 2011;6:e22616.","journal-title":"PLoS One"},{"key":"1332_CR39","doi-asserted-by":"publisher","first-page":"e32554","DOI":"10.1371\/journal.pone.0032554","volume":"7","author":"J Xu","year":"2012","unstructured":"Xu J, Qi X, Gong J, Yu M, Zhang F, Sha H, Gao X. Fstl1 antagonizes BMP signaling and regulates ureter development. PLoS One. 2012;7:e32554.","journal-title":"PLoS One"},{"key":"1332_CR40","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.neuron.2011.01.022","volume":"69","author":"KC Li","year":"2011","unstructured":"Li KC, Zhang FX, Li CL, Wang F, Yu MY, Zhong YQ, Zhang KH, Lu YJ, Wang Q, Ma XL, Yao JR, Wang JY, Lin LB, Han M, Zhang YQ, Kuner R, Xiao HS, Bao L, Gao X, Zhang X. Follistatin-like 1 suppresses sensory afferent transmission by activating Na+, K+-ATPase. Neuron. 2011;69:974\u201387.","journal-title":"Neuron"},{"key":"1332_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature11890","volume":"495","author":"GM Sundaram","year":"2013","unstructured":"Sundaram GM, Common JE, Gopal FE, Srikanta S, Lakshman K, Lunny DP, Lim TC, Tanavde V, Lane EB, Sampath P. \u2018See-saw\u2019 expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Nature. 2013;495:103\u20136.","journal-title":"Nature"},{"key":"1332_CR42","doi-asserted-by":"publisher","first-page":"e873","DOI":"10.1371\/journal.pone.0000873","volume":"2","author":"T Hansen","year":"2007","unstructured":"Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, Andreassen OA, Djurovic S, Melle I, Agartz I, Hall H, Timm S, Wang AG, Werge T. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One. 2007;2:e873.","journal-title":"PLoS One"},{"key":"1332_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nbd.2011.12.029","volume":"46","author":"NJ Beveridge","year":"2012","unstructured":"Beveridge NJ, Cairns MJ. MicroRNA dysregulation in schizophrenia. Neurobiol Dis. 2012;46:263\u201371.","journal-title":"Neurobiol Dis"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1332-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1332-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T08:12:27Z","timestamp":1589962347000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1332-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1332"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1332-0","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,22]]},"assertion":[{"value":"7 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee of Nagoya University (Approval No. 30248). Animals were handled in accordance with the guidelines established by the Institutional Animal Care and Use Committee of Nagoya University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"295"}}